Teclistamab in patients with multiple myeloma and impaired renal function

被引：11
|
作者：
Joiner, Laura [1 ]
Bal, Susan [2 ]
Godby, Kelly N. [2 ]
Costa, Luciano J. [2 ,3 ]
机构：
[1] Univ Alabama Birmingham, Dept Pharm, Birmingham, AL USA
[2] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL USA
[3] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, 1802 6th Ave South, Birmingham, AL 35294 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 11期
关键词：
D O I：
10.1002/ajh.27063
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E322 / E324
页数：3
相关论文
共 50 条
  • [41] RAPID IMPROVEMENT IN RENAL FUNCTION IN PATIENTS WITH MULTIPLE MYELOMA AND RENAL FAILURE TREATED WITH BORTEZOMIB
    Qayum, A.
    Aleem, A.
    Al-Diab, A.
    Al-Sagheer, A.
    Niaz, F.
    Al-Momen, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 435 - 435
  • [42] Impaired osteogenesis in multiple myeloma patients.
    Masellis, AM
    Oken, MM
    Evenson, K
    Westendorf, J
    BLOOD, 2001, 98 (11) : 301B - 301B
  • [43] Bortezomib in renally impaired multiple myeloma patients
    Miguel, J. F. San
    Richardson, P. G.
    Sonneveld, P.
    Schuster, M. W.
    Irwin, D.
    Stadtmauer, E. A.
    Facon, T.
    Harousseau, J. L.
    Ben-Yehuda, D.
    Lonial, S.
    Goldschmidt, H.
    Reece, D.
    Blade, J.
    Boccadoro, M.
    Neuwirth, R.
    Boral, A. L.
    Esseltine, D. L.
    Anderson, K. C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 214 - 215
  • [44] Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma
    Girgis, Suzette
    Lin, Shun Xin Wang
    Pillarisetti, Kodandaram
    Verona, Raluca
    Vieyra, Diego
    Casneuf, Tineke
    Fink, Damien
    Miao, Xin
    Chen, Yang
    Stephenson, Tara
    Banerjee, Arnob
    Hilder, Brandi W.
    Russell, Jeffery
    Infante, Jeffrey
    Elsayed, Yusri
    Smit, Jennifer
    Goldberg, Jenna D.
    BLOOD ADVANCES, 2023, 7 (04) : 644 - 648
  • [45] Cytomegalovirus Reactivation in Patients with Multiple Myeloma Treated with Teclistamab: Risk Factors and Clinical Impact
    Pei, Charles
    Blackburn, Lisa
    Sharma, Nidhi
    Bumma, Naresh
    Khan, Abdullah Mohammad
    Devarakonda, Srinivas
    Umyarova, Elvira
    Benson, Don
    Rosko, Ashley
    El Boghdadly, Zeinab
    Cottini, Francesca
    BLOOD, 2024, 144 : 4717 - 4718
  • [46] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    Shao-long He
    Yu-hang Cheng
    Di Wang
    Meng-lei Xu
    Yi-mei Que
    Yan-jie Xu
    Liang-ming Ma
    Chun-rui Li
    Jian-feng Zhou
    Current Medical Science, 2021, 41 : 474 - 481
  • [47] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    He, Shao-long
    Cheng, Yu-hang
    Wang, Di
    Xu, Meng-lei
    Que, Yi-mei
    Xu, Yan-jie
    Ma, Liang-ming
    Li, Chun-rui
    Zhou, Jian-feng
    CURRENT MEDICAL SCIENCE, 2021, 41 (03) : 474 - 481
  • [48] Longitudinal Evaluation of Renal Function in Multiple Myeloma
    Antlanger, Marlies
    Reiter, Thomas
    Pablik, Eleonore
    Minichsdorfer, Christoph
    Porpaczy, Edit
    Rasoul-Rockenschaub, Susanne
    Gisslinger, Heinz
    Agis, Hermine
    Krauth, Maria-Theresa
    BLOOD, 2017, 130
  • [49] LONGITUDINAL EVALUATION OF RENAL FUNCTION IN MULTIPLE MYELOMA
    Antlanger, Marlies
    Pablik, Eleonore
    Reiter, Thomas
    Minichsdorfer, Christoph
    Porpaczy, Edit
    Rasoul-Rockenschaub, Susanne
    Gisslinger, Heinz
    Agis, Hermine
    Krauth, Maria-Theresa
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [50] Impaired renal function in progressive multiple sclerosis
    Calabresi, PA
    Austin, H
    Racke, MK
    Goodman, A
    Choyke, P
    Maloni, H
    McFarland, HF
    NEUROLOGY, 2002, 59 (11) : 1799 - 1801
12345